The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
Autor: | Ranjini Sankaranarayanan, Chaitanya K. Valiveti, D. Ramesh Kumar, Siddharth S. Kesharwani, Joy Scaria, Hemachand Tummala, Teresa Seefeldt, G. Jayarama Bhat, Severine Van Slambrouck |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Cancer Research Metabolite Phloroglucinol colorectal cancer lcsh:RC254-282 Article 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine CDKs and CDK inhibitors Cyclin-dependent kinase chemistry.chemical_classification biology Chemistry Kinase Cell growth lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens In vitro 3. Good health Amino acid 030104 developmental biology Oncology Biochemistry 030220 oncology & carcinogenesis biology.protein flavonoids and polyphenols cyclins CDK inhibitor |
Zdroj: | Cancers, Vol 11, Iss 3, p 427 (2019) Cancers Volume 11 Issue 3 |
ISSN: | 2072-6694 |
Popis: | Flavonoids have emerged as promising compounds capable of preventing colorectal cancer (CRC) due to their anti-oxidant and anti-inflammatory properties. It is hypothesized that the metabolites of flavonoids are primarily responsible for the observed anti-cancer effects owing to the unstable nature of the parent compounds and their degradation by colonic microflora. In this study, we investigated the ability of one metabolite, 2,4,6-trihydroxybenzoic acid (2,4,6-THBA) to inhibit Cyclin Dependent Kinase (CDK) activity and cancer cell proliferation. Using in vitro kinase assays, we demonstrated that 2,4,6-THBA dose-dependently inhibited CDKs 1, 2 and 4 and in silico studies identified key amino acids involved in these interactions. Interestingly, no significant CDK inhibition was observed with the structurally related compounds 3,4,5-trihydroxybenzoic acid (3,4,5-THBA) and phloroglucinol, suggesting that orientation of the functional groups and specific amino acid interactions may play a role in inhibition. We showed that cellular uptake of 2,4,6-THBA required the expression of functional SLC5A8, a monocarboxylic acid transporter. Consistent with this, in cells expressing functional SLC5A8, 2,4,6-THBA induced CDK inhibitory proteins p21Cip1 and p27Kip1 and inhibited cell proliferation. These findings, for the first time, suggest that the flavonoid metabolite 2,4,6-THBA may mediate its effects through a CDK- and SLC5A8-dependent pathway contributing to the prevention of CRC. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |